儿童1型糖尿病患者的自我护理活动
Mirjana Smudja1,2, Tatjana Milenković3, Ivana Minaković2,4
1Department of Higher Medical School, Academy for Applied Studies Belgrade, Belgrade, Serbia.
PloS one
|March 5, 2024
概括
患有1型糖尿病的儿科患者经常在自我护理的坚持下扎,尽管他们报告了独立性. 父母参与胰岛素治疗不足与1型糖尿病儿童严重低血糖有关.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 糖尿病自我管理研究 研究 研究
- 儿童健康行为行为
背景情况:
- 1型糖尿病的自我管理需要儿科患者的自主权和家长的合作.
- 在孩子过渡到自我照顾时,评估孩子的坚持和父母的参与至关重要.
- 了解影响自我护理的社会人口统计学和临床因素至关重要.
研究的目的:
- 根据患者的社会人口统计和临床特征来评估自我护理遵守的差异.
- 为了确定家长参与儿科糖尿病管理的程度.
- 分析与患者特征相关的儿科自我管理行为.
主要方法:
- 进行比较的横截面和相关性研究设计.
- 包括被诊断患有1型糖尿病 (持续时间≥3个月) 的182名儿科患者.
- 利用社会人口统计问卷,依从性/家长参与调查和临床数据文档.
主要成果:
- 71%的参与者表现出不遵守自我护理任务.
- 尽管如此,78%的患者报告说,在控制糖尿病方面,他们已经独立了.
- 在胰岛素治疗中父母参与度较低预测了严重的低血糖症.
结论:
- 儿童1型糖尿病患者表现出显著的自主权,但矛盾的是,报告的坚持不佳.
- 较小的孩子 (8-12岁) 更多地依赖父母的支持,特别是胰岛素治疗.
- 父母参与胰岛素的管理至关重要;它的缺失增加了严重低血糖的风险.
相关概念视频
Diabetes: Management and Pharmacotherapy
282
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
282
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Insulin: Dosing Regimen and Adverse Effects
170
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
170
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes: Symptoms, Diagnosis, and Complications
534
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
534
Hypoglycemia and Glucagon
260
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
260


